Phosphatidylserine
Phosphatidylserine is a dietary supplement with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
TCP-600 Supplementation and Performance Response in Professional Football Players
Multi-Ingredient Supplementation in Professional Football Players
ADAM17 and Vascular Function in Diabetes
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
Phosphatidylserine Improves Cognitive Function in the Elderly
Clinical Trials (8)
TCP-600 Supplementation and Performance Response in Professional Football Players
Multi-Ingredient Supplementation in Professional Football Players
ADAM17 and Vascular Function in Diabetes
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
Phosphatidylserine Improves Cognitive Function in the Elderly
The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists
The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
All 8 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 8